Archive for January, 2011

AMLN Reports Reduction In Net Loss For The Fourth Quarter And Full Year 2010

Friday, January 28th, 2011

Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) jumped 7.66% following the Company’s reporting of its fourth quarter 2010results.

Shares traded hands on high volume of 9.507 million shares as compared to the average trading volume of 1.88 million shares in the range of $15.75-$16.65.

Revenue in total was reported at $162.3 million with a robust increase seen in the revenues under collaborative agreements to $11.875 million from the prior year period revenue of $1.25 million. The fourth quarter revenue comprised of $136.4 million sales from BYETTA and $25.9 million sales from SYMLIN(R) (pramlintide acetate) injection.

Full year revenues also decreased to $668.8 million from total revenues of $758.4 million recorded in 2009 of which $651.1 million was from the product sales.

Research and development costs declined by $15.2 million to $35 million due to lower incentive compensation costs and decreased expenses for BYDUREON pre-launch activities. Full year research and development costs also represented a decline of 7.5% from the last year expense of %185.1 million mainly due to development expense cost-sharing with Takeda and reduction in the expenses for the obesity programs.

Operating loss for the quarter reduced to $10.31 million on year-over-year basis while excluding special items the Company posted an operating profit of $22.927 million as compared to a non-GAAP operating loss of $17.025 million reported in the same period earlier year. Non-GAAP adjustments relate to Stock-based compensation, Depreciation and amortization, Amortization of deferred revenue and Restructuring.

The company on GAAP basis incurred net loss of $19.2 million or $0.13 per diluted share compared to loss of $50.3 million or $0.35 per diluted share incurred in the corresponding period previous year. On yearly basis the GAAP net loss decreased to $152.3 million or $1.06 per diluted share as compared to loss of $186.3 million or $1.32 per diluted share incurred in 2009.

Amylin Pharmaceuticals, Inc. (Amylin) is a biopharmaceutical company engaged in discovery, development and commercialization of medicines. The Company is marketing two first-in-class medicines to treat diabetes, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection.

RAD Spikes On January Sales Data Release

Friday, January 28th, 2011

Rite Aid Corporation (NYSE:RAD) was up by 15.45% following the company’s release of its January sales data.

Shares of the drug retailer traded hands on high volume of 26.36 million shares as compared to the average trading volume of 4.49 million shares to hit its day high of $1.27. Its 52-week trading range is $0.86 and $1.77 and its shares are currently trading above its 50-Day Moving Average and 200-Day Moving Average of $0.96 and $0.95 respectively.

For the four weeks ended January 22, 2011 the Company reported 1.1% increase in its same store sales over the prior-year period with the front end same store sales growing 2.2% and the pharmacy same store sales growing by 0.6% due to negative impact of 2.3% from the introduction of new generics.

Prescription count at comparable stores and Total drugstore sales were flat at $1.913 billion in the four week period bringing the 47 week total drugstore sales to $22.68 billion as compared to $23.135 billion recorded in the same period year earlier.

The 47 week period same store sales decreased by 0.9% with 1.1% decrease observed in the Company’s pharmacy same store sales and 0.4% decrease in front-end same store sales.

The Company had on its third quarter reporting provided full year revenue guidance of $25-$25.2 billion with same store sales declining in the range of 1.5%-0.9%. RAD had lowered its anticipated earnings to $655 million or $0.74 per diluted share and $525 million or $0.60 per diluted share on third quarter results and its lower expectation for same store sales in the fourth quarter.

The Company’s 39 week ended November 27, 2010 revenues were $18.758 billion and its four week period ending December 25, 2010 revenues were $2.081 billion.

Rite Aid Corporation is a retail drugstore chain in the United States. The Company operates its drugstores in 31 states across the country and in the District of Columbia.

S&P Falls Short Of 1300 Close

Thursday, January 27th, 2011

The S&P 500 rose 2.91 points, or 0.2 percent, to close at 1,299.54, its highest close since Aug. 28, 2008, which was also the last time the broad market index closed above 1,300.  The market seemed to stall as it hit the major thresholds, but a sell-off doesn’t appear to be in the offing, at least yet. However, the broad-market barometer did manage to topple this familiar foe in intraday trading, topping out at 1,301.29 – a feat not accomplished since September 2008.

Stocks spent the session dancing around breakeven today, as the Street sipped a cocktail of mixed earnings and economic reports. On the bullish hand, Dow component Caterpillar (CAT) and video rental vixen Netflix (NFLX) wowed investors with their respective earnings reports, with the latter even tagging a new record high. In the same vein, the National Association of Realtors’ pending-home sales index jumped 2% in December, nearly twice the increase expected by economists. On the bearish hand, however, a steeper-than-expected quarterly loss from D.R. Horton (DHI) tempered any housing-related enthusiasm, as did unexpectedly dismal data on both jobless claims and durable goods. Likewise, disappointing earnings reports from both AT&T (T) and Procter & Gamble (PG) attempted to rain on the blue chips’ parade. Against this ambiguous backdrop, the major market indexes eked out gains by the close, though both the Dow and S&P 500 Index failed to conquer round-number resistance.

I’m still anticipating a pull back sometime soon. I’ve been calling for a correction for the last 2 weeks as markets have stalled just shy of 1300. On average, the correction, when it happens is about 9 percent. I think it will be more in the neighborhood of 6 to 8 percent this time. By year end, however, I expect the market will deliver returns in the upper-single-digits to double-digits.

Certain indicators confirm the notion that the market is due for a sell-off, such as record numbers of stocks hitting 52-week highs. Another indicator: smaller capitalization stocks have tended not to outperform large caps in recent weeks.

Generally speaking, the market remains positive. Any pullback that we see will mostly be short term in nature.

Obama’s Future Plans After State Of The Union Address

Thursday, January 27th, 2011

Obama had noted the stock market has been roaring with company profits higher than ever. The truth of the matter is that trillions of dollars injected supporting the markets will tend to lift stocks to upside significantly. I thought the delivery of the speech with great with a rating of an A however the speech lacked sustenance. Lack of details on how we should tackle the debt issue was a big factor. We need to tackle the debt issue from the head on in addition to cutting further Quantative Easings.

In his State of the Union address, Obama said the U.S. will invest in electric cars, high-speed trains, high-speed Internet, clean energy, education, and biotechnology, to name but some of the big-picture items where investment opportunities will surface over the next two decades.

Energy

One of the key areas of relevance to investors is energy, where formulating a policy that will reduce the country’s dependence on foreign oil will involve more spending in alternative energy, nuclear and coal. Obama had suggested we cut subsidies paid to the oil companies and forward those subsidies to tomorrow’s energy. Greater government subsidies for alternative-energy production could be a positive for solar, wind and hydro-generating companies.” At the sector and industry level, policy efforts to both reduce emissions of pollutants from existing fuel sources and promote energy efficiency should be positives for the industrials and technology sectors. Within industrials, large-scale investments by electric utilities to either retrofit coal-fired plants or shift production to cleaner gas or nuclear production should benefit engineering and construction companies.

investors might want to approach investing in clean- and alternative-energy companies as if they were venture capitalists. There is a lot of technology and business risk associated with the companies in this sector, he said. You should invest in ETFs because many [companies] will fail and one or two will succeed and we don’t know which ones will work out.

Here are a few suggestions:

Claymore Global Solar Energy (TAN)8.03, is the ETF vehicle of choice for investing in the solar-energy sector. PowerShares Global Clean Energy(PBD) 14.34,  and Market Vectors Global Alternative Energy (GEX) 20.65, both provide “broader coverage of the entire alternative-energy space with a much higher level of market liquidity.”

Infrastructure

An increase in spending on infrastructure and science will not only improve the longer term competitiveness of the U.S. manufacturing industry but could also potentially boost the industrial sector in the near to medium term. Increased infrastructure spending in roads, railways and runways would be positives for construction-services companies and for the materials sector.

Some top-rated companies in the materials sector include Vulcan Materials Company (VMC)43.47, and China Gerui Advance Materials Group (CHOP) 5.88. Another possibility is Caterpillar, Inc. (CAT) 97.55.  Quanta Services (PWR) 23.48   Any initiatives that stimulate the labor market, lead to improvement in job creation and reduce unemployment will be a positive for consumer spending and the consumer sectors.

Electric cars

Electric cars are the future. Lithium batteries and future battery technology will propel this country and steer it away from foreign oil.

At the moment, I’m not too fond of investing in companies in the electric-car space. The challenge in those industries right now is that they need government support. It’s wonderful that the support is there, but that government support could be temporary and could change. In other words, there’s uncertainty about the permanence of the government support and that means it’s hard for those making long-term investments to view this sector as one filled with opportunity. Most Americans still aren’t likely to buy an electric car in the next 10 years due to the fact it’s too expensive. Tesla Motors (TSLA) 24.75 is the only pure electric car company play. GM has the Volt which is pretty impressive itself but priced too high. Tata Motors Limited (TTM) 26.34, the is the obvious electric-car plays.

Health care

Emphasis on reducing health-care costs by improving electronic medical records benefits health-care information technology companies.  What’s more, the life-science industry, such as manufacturers of testing equipment, should also benefit from regulations and increased government spending on food, air, water and drug safety. Morningstar has given the following health-care companies its highest rating: Abbott Laboratories (ABT) 46.55, Roche Holding AG (RHHBY) 38.60, TomoTherapy (TOMO) 3.58, Vanda Pharmaceuticals Inc. (VNDA) 8.18, and WellPoint Inc. (WLP)62.55.

Stock Losers After Earnings (STJ, ABT, FMBI)

Wednesday, January 26th, 2011

St. Jude Medical, Inc. (NYSE:STJ) dropped 1.81% to $41.85. The company reported higher fourth-quarter earnings and stronger sales of implantable heart defibrillators, and forecast continued growth in 2011.

Net earnings rose to $206.4 million, or 62 cents per share, from $189.6 million, or 57 cents per share, a year earlier. Excluding items, earnings were 75 cents per share, a penny over the average estimate on Wall Street, according to Thomson Reuters.

Revenue exceeded expectations of $1.32 billion, rising to $1.35 billion from $1.20 billion.

Abbott Laboratories (NYSE:ABT) fell 2.11% to $46.95. The company said it earned $1.44 billion, or 92 cents per share, in the quarter, with results tempered by costs of recent acquisitions. That compared with $1.54 billion, or 98 cents per share, a year earlier.

Excluding special items, earnings were $1.30 per share, a penny better than analysts’ average forecast, according to Thomson Reuters.

First Midwest Bancorp, Inc. (NASDAQ:FMBI) lost 6.19% to $11.82. Fourth-quarter net loss applicable to common shareholders was $30.3 million, or 41 cents a share, compared with a loss of $39.5 million, or 73 cents a share, in the year-ago quarter. Analysts expected a loss of 3 cents a share, according to Thomson Reuters.

In the last one month of trading sessions, the stock jumped more than 6%.

Regis Corporation Common Stock (NYSE: RGS) Reports 4Q below Street Expectations

Wednesday, January 26th, 2011

Regis Corporation Common Stock (NYSE: RGS) went down by 2.33% or 41 cents to trade close at $17.41 after the company reported second fiscal quarter EPS of 25 cents below the consensus of 28 cents.

Shares of the Hair-salon operator is trading with lower volume of 346,425 shares compared to the daily average volume of 902,695 shares after opening at $17.52 and in the range of $17.00-$17.56. The market capitalization of the stock stands at $987.73 million with P/E of 21.70 and beta of 1.21. The stock has 52 week trading range of $12.84-$21.69.

Today, the Company reported fiscal second quarter financial results. It posted net income of $14.51 million or 24 cents a share in the second fiscal quarter compared to the net income of $18.15 million or 30 cents a share in the same period last year.

Excluding costs associated with the company’s review of strategic alternatives, the company recorded EPS of 25 cents a share, below the street consensus of 28 cents a share. The miss was due to a higher cost of service and product than expected, and was partially offset by a lower than expected tax rate.

Revenue for the quarter slumped 0.2% to $574 million from $575 million in the same quarter last year. Total same-store sales for the quarter declined 1.3% compared to the decline of 3.7% in the previous year quarter.

Cost of service as a percent of sales increased 80 basis points year over year to 57.9% this quarter.

The company expects to hit the low end of it’s previously issued FY2011 same store sales and EBITDA ranges of -1% to +2% and $235million to 270 million. Analysts were expecting the Company to report EBITDA of $252 million for FY2011.

Regis Corporation owns, operates, and franchises hairstyling and hair care salons in the United States, the United Kingdom, Canada, Puerto Rico, and internationally.

Financial Meltdown Was ‘Avoidable’ Says Inquiry

Wednesday, January 26th, 2011

Published by the New York Times:

It’s how ironic it took the Financial Crisis Inquiry Commission 3 years to determine what caused the Financial Meltdown and if it was preventable. I’ve been stressing that loose lending laws created by in small part by the Clinton administration of “The Home Affordable Act” which paved the way for the excessive Sub-prime market as well as the excessive lack of policies set by the Bush Administration and Greenspan. Was this preventable, absolutely. When Bernanke was asked in 2006 and 2007 if we’ll see a housing crash, he stated it was contained. Lets not also forget the underwriters and rating agencies had a hand in this. Well, we know the end result subsequent to that remark. Lehman Bro. faltered and almost followed through with The Great Depression II. We need our elected officials to take a proactive approach. Manywere hurt during this crisis. Approximately 10 million people have lost their jobs. In the end I hope something of great fortune comes to world after this crisis.

The results by the Committee.

The 2008 financial crisis was an “avoidable” disaster caused by widespread failures in government regulation, corporate mismanagement and heedless risk-taking by Wall Street, according to the conclusions of a Congressional inquiry.

The government commission that investigated the financial crisis casts a wide net of blame, faulting two administrations, the Federal Reserve and other regulators for permitting a calamitous concoction: shoddy mortgage lending, the excessive packaging and sale of loans to investors, and risky bets on securities backed by the loans. “The greatest tragedy would be to accept the refrain that no one could have seen this coming and thus nothing could have been done,” the panel wrote in the report’s conclusions. “If we accept this notion, it will happen again.”

While the panel, the Financial Crisis Inquiry Commission, accuses several financial institutions of greed, ineptitude, or both, some of its most grave conclusions concern government failings, with embarrassing implications for both political parties.

Many of the findings have been widely described, but its synthesis of interviews, documents and testimony, along with its government imprimatur, give it a sweep and authority that the commission hopes will shape the public consciousness. The full report is expected to be released as a 576-page book on Thursday. When the bipartisan commission was set up in May of 2009, the intent of Congress and the president was to produce a comprehensive examination of the causes of the crisis. The report, aimed at a broad audience, was based on 19 days of hearings as well as interviews with more than 700 witnesses; the commission has pledged to release a trove of transcripts and other raw material online. The document is intended to be the definitive account of the crisis’s causes, but its authors may already have failed in achieving that aim.

Of the 10 commission members, only the 6 appointed by Democrats endorsed the final report. Three Republican members have prepared a dissent; a fourth Republican, Peter J. Wallison, a former Treasury official and White House counsel to President Ronald Reagan, has written a dissent, calling government policies to promote homeownership the primary culprit for the crisis. The report itself finds fault with two Fed chairmen: Alan Greenspan, a skeptic of regulation who led the central bank as the housing bubble expanded, and his successor, Ben S. Bernanke, who did not foresee the crisis but then played a crucial role in the response. It criticizes Mr. Greenspan for advocating financial deregulation and cites a “pivotal failure to stem the flow of toxic mortgages” under his leadership as “the prime example” of government negligence.

It also criticizes the Bush administration’s “inconsistent response” to the crisis — allowing Lehman Brothersto go bankrupt in September 2008, for example, after earlier bailing out another bank, Bear Stearns, with help from the Fed — “added to the uncertainty and panic in the financial markets.”

Like Mr. Bernanke, Mr. Bush’s Treasury secretary, Henry M. Paulson Jr., predicted in 2007 — wrongly it turned out — that the subprime meltdown would be contained, as the report notes.

Democrats also come under fire. The 2000 decision to shield over-the-counter derivatives from regulation, made during the last year of President Bill Clinton’s term is called “a key turning point in the march toward the financial crisis.”

Timothy F. Geithner, who was president of the Federal Reserve Bank of New York during the crisis and is now President Obama’s Treasury secretary, also comes under criticism; the report finds that the New York Fed “could have clamped down” on excesses by Citigroup in the lead-up to the crisis and, just a month before Lehman’s collapse, was “still seeking information” on the vulnerabilities from Lehman’s exposure to more than 900,000 derivatives contracts. Former and current officials named in the report, as well as financial institutions, declined on Tuesday to comment on the report before it was released , or did not respond to requests for comment. The report will probably reignite debate over the outsize influence of Wall Street; it says that regulators “lacked the political will” to scrutinize and hold accountable the institutions they were supposed to oversee. The financial sector spent $2.7 billion on lobbying from 1999 to 2008, while individuals and committees affiliated with the industry made more than $1 billion in campaign contributions.

The report does knock down — at least partly — several early theories for the financial crisis. It says the low interest rates brought about by the Fed after the 2001 recession “created increased risks” but were not chiefly to blame. It says that Fannie Mae (FNM)  0.491 and Freddie Mac, the mortgage finance giants, “contributed to the crisis but were not a primary cause.” And in a finding likely to upset conservatives, it says that “aggressive homeownership goals” set by the government as part of a “philosophy of opportunity” were not major culprits.

On the other hand, the report is unsparing in its treatment of regulators. It finds that the Securities and Exchange Commission failed to require big banks to hold more capital to cushion losses and halt risky practices, and that the Fed “neglected its mission” to protect the public.

It says that the Office of the Comptroller of the Currency, which regulates national banks, and the Office of Thrift Supervision, which oversees savings-and-loans, blocked state regulators from reining in lending abuses because they were “caught up in turf wars.” “The crisis was the result of human action and inaction, not of Mother Nature or computer models gone awry,” the report states. “The captains of finance and the public stewards of our financial system ignored warnings and failed to question, understand and manage evolving risks within a system essential to the well-being of the American public. Theirs was a big miss, not a stumble.”

“The crisis was the result of human action and inaction, not of Mother Nature or computer models gone awry,” the report states. “The captains of finance and the public stewards of our financial system ignored warnings and failed to question, understand and manage evolving risks within a system essential to the well-being of the American public. Theirs was a big miss, not a stumble.”

Portions of the dissents are also included in the report, which is being published as a paperback book (with a cover price of $14.99) by PublicAffairs, along with an official version by the Government Printing Office. The commission’s chairman, Phil Angelides, a Democrat and former California state treasurer, has tried to keep the book under wraps, even directing the publisher to prevent bookstores from getting it before the eve of the Thursday release. He declined to comment. The report’s immediate implications may be felt more in the political realm than in public policy. The Dodd-Frank law overhauling the regulation of Wall Street, signed in July, takes as its premise the same regulatory deficiencies cited by the commission. But the report is sure to factor in the debate over the future of Fannie Mae and Freddie Mac, which have been government-run since 2008.

Though the report documents questionable practices by mortgage lenders and careless betting by banks, one striking finding is its portrayal of bumbling incompetence, among corporate chieftains.

It quotes Citigroup (C)  4.835 // executives admitting that they paid little attention to the risks associated with mortgage securities. Executives at the American International Group (AIG), another bailout recipient, were found to be blind to its $79 billion exposure to credit default swaps, a kind of insurance that was sold to investors seeking protection against a drop in the value of securities backed by risky home loans. At Merrill Lynch, top managers were caught unaware when seemingly secure mortgage investments suddenly resulted in billions of dollars in losses.

By one measure, the nation’s five largest investment banks had only $1 in capital to cover losses for about every $40 in assets, meaning that a 3 percent drop in asset values could wipe out the firm. The banks hid their excessive leverage using derivatives, off-balance-sheet entities and other devices, the report found. The speculative binge was abetted by a giant “shadow banking system” in which the banks relied heavily on short-term debt. “When the housing and mortgage markets cratered, the lack of transparency, the extraordinary debt loads, the short-term loans and the risky assets all came home to roost,” the report found. “What resulted was panic. We had reaped what we had sown.”

The report is dotted with literary flourishes. It calls credit-rating agencies “cogs in the wheel of financial destruction.” Paraphrasing Shakespeare’s Julius Caesar, it states, “The fault lies not in the stars, but in us.” Of the banks that bought created, packaged and sold trillions of dollars in mortgage-related securities, it says: “Like Icarus, they never feared flying ever closer to the sun.”

ABT provides for 10% growth in its Q1 2011 earnings

Wednesday, January 26th, 2011

Abbott Laboratories (NYSE:ABT) was trading at $48.05 after the Company reported a 10.2% growth in its net earnings for the quarter ended Dec. 31, 2010.

Shares declined 0.85% on trading at a volume of 4.04K shares as compared to its average trading volume of 8.45 million shares. Currently the shares are trading above its 50-Day Moving Average of $47.75 but below its 200-Day Moving Average of $49.64.

Sales for the quarter increased 13.4% on a worldwide basis primarily driven by a growth of 22.5% seen in the Company’s worldwide pharmaceutical sales which also includes contribution from the Solvay and Piramal acquisitions.

The Company’s Worldwide Vascular Sales increased 13.7% to $822 million while the Worldwide Vascular Sales for the full year 2010 increased 18.6% to $3194 million. Full year 2010 pharmaceutical sales were reported at $19.894 billion representing a sales growth of 20.7%.

Total sales generated in the quarter was $9.968 billion a growth of 13.4% from the Q4 2009 total sales of $8.79 billion while full year 2010 sales totaled $35.167 billion as compared to 2009 sales of $30.765 billion. The growth in sales was majorly due to Pharmaceutical sales increase of 22.5% including above 10% growth observed across Company’s product HUMIRA and 19% growth in its global lipid franchise sales. ABT also posted double-digit growth in Worldwide Vascular sales in consequence to international vascular sales growth of approximately 37 percent.

Gross margin ratio was 58.3% on an adjusted basis resulting in an operating profit of $1.83 billions and net income of $1.441 billion or $0.92 per diluted share for the quarter. Non-GAAP net earnings reported by the Company came at $1.30 per diluted share or $2.025 billion an increase of 10.2% as compared to net earnings of $1.845 billion or $1.18 per diluted share excluding after-tax charges of $170 million, or $0.11 per share; $99 million, or $0.07 per share, primarily for acquisition integration and cost reduction initiatives, and $37 million, or $0.02 per share, primarily related to inventory write-offs.

Abbott expects bardoxolone to enter Phase 3 clinical trials in early 2011, an investigational treatment for CKD; and anticipates earning $4.54 to $4.64 per diluted share for the full-year 2011 reflecting 10% growth while projecting earnings per share of $3.76 to $3.86 for the full-year 2011 on GAAP basis.

Abbott Laboratories (Abbott) is engaged in discovery, development, manufacture, and sale of diversified line of healthcare products.

Markets Fights Its Way Back Up

Tuesday, January 25th, 2011

After tagging a fresh multi-year high of 11,985.97 in early trading, the DJIA  pulled back to finish on a loss of 3.33 points, or 0.03%. By the close, 15 of the Dow’s 30 components ended in the black, with Wal-Mart Stores, Inc. (WMT) advancing 2.2%. Unsurprisingly, American Express paced the Dow’s decliners, shedding 2.2%. 

Meanwhile, after flirting with breakeven all day, the S&P 500 Index (SPX – 1,291.18) clawed its way to a gain of 0.34 point, or 0.03%, ending the session just north of the round-number 1,290 level. Not to be outdone, the Nasdaq Composite (COMP – 2,719.25) finished the session 1.7 points, or 0.06%, higher. 

The Dow on Monday settled just a stone’s throw from the psychologically significant 12,000 level, so perhaps it’s not too surprising that stocks pulled back right out of the gate this morning. However, to be fair, some genuinely lackluster data also contributed to the day’s downbeat mood. Traders learned that Britain’s fourth-quarter gross domestic product (GDP) contracted 0.5% on a sequential basis — defying expectations for a modest improvement, and marking the U.K.’s first quarterly GDP decline since 2009. Meanwhile, in the U.S., homebuilding stocks turned lower as the S&P Case-Shiller home price index retreated 1.6% in November. Earnings news wasn’t too encouraging, either, with traders responding to disappointing quarterly reports from blue chips 3M Company (MMM), American Express (AXP), and Johnson & Johnson (JNJ).

And — as if that weren’t enough news to drive the day’s action — traders are also anticipating President Obama’s State of the Union remarks. Ahead of tonight’s speech, ABC News reported that the Commander in Chief is likely to propose an overall spending freeze — a bit of news that gave Treasurys a boost in early afternoon trading. The net result of this data deluge was a mixed day for the major market indexes. 

Crude futures extended their losing streak to a sixth straight session, with traders casting a wary eye on bloated domestic inventories. Tomorrow’s regularly scheduled report from the Energy Information Administration (EIA) is expected to reveal another increase in crude stockpiles, raising concerns that supply may have outpaced demand. Against this backdrop, an uptick in the U.S. dollar was simply the final nail in the coffin for black gold. Crude oil for March delivery ended on a deficit of $1.68, or 1.9%, at a new eight-week low of $86.19 per barrel.Gold futures backpedaled to a three-month closing low today, with the malleable metal moving inversely to a stronger greenback. The popular safe-haven asset was also pressured by a stronger-than-forecast rise in January’s consumer confidence index, as reported by the Conference Board. By the close, gold for February delivery shed $12.20, or 0.9%, to settle at $1,332.30 per ounce — its lowest daily finish since Oct. 27.

NASDAQ Stock of the Week: Rediff.com India Limited (NASDAQ: REDF)

Tuesday, January 25th, 2011

Rediff.com India Limited (ADR) (NASDAQ:REDF) surged 101.99% in last 1 month trading sessions all the way from $4.02 on Dec 15 to $8.12 on Jan 14. The stock surged 45.78% in past 5 trading sessions.

Shares of the company remained among top gainers on January 14, 2011 surged 11.65% with the closing price of $8.12. The stock climbed to its new 52 week high of $8.39 with the overall volume of 2.71 million shares compared to the daily average volume of 954,805 shares. The total market capitalization stands at $237.36 million with beta of 3.05. The stock has 50 day & 200 day moving average of $4.86 & $3.53 respectively.

Of 1.2 billion people in India, only 9 million people have access to broadband Internet and REDF is the 10th most trafficked site in India. India intends to increase its number of broadband connections by 700% next year, and REDF is looking to invest on it.

On Dec 22, Rediff’s social music streaming service SongBuzz announced their first 10 of ’10 list, the top 10 Bollywood songs of the year which is based on the songs that users have been streaming on the service.

On Dec 15, the company announced International games are now available on Rediff’s social media platform MyPage. It said that International game developers MiniClip and King.com from the UK, Lumosity, Canadian Revlry, Platogo from Austria, Disney and India Games have uploaded their gaming offerings on Rediff PlayGully, an integrated platform for both online gaming and social media. This enhances online gaming offering and enriches user experience for millions.

Rediff.com India Limited (Rediff) along with its subsidiaries, is engaged in business of providing online Internet based services, focusing on India and the global Indian community. The Company operates in two segments: India Online business and US Publishing business.